FDA Announces Warning for Some Birth Control Pills

.

FDA Announces Warning for Some Birth Control Pills

As per recent reports, it has been revealed that FDA has asked the birth pill manufacturers to carry a warning if their drug carries the hormone drospirenone. The warning should contain the message that person taking the pill can develop fatal blood clots.

Some of the many birth control drugs, which will need to carry the warning, are Beyaz, Safyral, Yasmin, and Yaz and Gianvi, Loryna, Ocella and Zarah. The FDA said that the drugs, which carry the hormone, increase the risk of developing blood clots by three times. However, no such risk is present in other drugs, which do not carry the hormone drospirenone.

It has been found that changes in the labeling were proposed at an FDA advisory committee in December 2011, but it is now that the proposal has been passed. It is, however, recommended that women should consult their respective GPs before they start taking any birth control pill.

"Women who use birth control pills with drospirenone (like Yaz) may have a higher risk of getting a blood clot”, read the US Food and Drug Administration website.

Experts were of the view that drospirenone is nothing but a synthetic version of progesterone, a female sex hormone.


Latest News

Though Wages in Japan Increase But It’s not Enough to Beat Inflation
Jack Ma Prepares for Second Alibaba IPO
RBA Feels Currency Overrated: Keeps Record Low Benchmark Rate
U.S. Business Lobby Express Concerns Saying Antitrust Probes in China Unfair
First dengue fever outbreak in 70 years in Japan
Rise in skin cancer due to cheap holidays
Cardio and wine is a great combination
Surrogacy is a form of exploitation: Ekman
Cuba Trims Down on Amount of Goods Which can be Carried by Travellers
Barclays Will Sell Its Spanish Businesses To CaixaBank In a Deal of 800 Million
Withdrawal in China’s Purchasing Managers' Index Amplifies Calls for Policy Easi
The Ukraine Mayhem Leads Euro to a Fresh One Year Low